Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Thrombocytopenia associated with dialysis treatments.

Posadas MA, Hahn D, Schleuter W, Paparello J.

Hemodial Int. 2011 Jul;15(3):416-23. doi: 10.1111/j.1542-4758.2011.00561.x. Epub 2011 Jun 28. Review.

PMID:
21711442
2.

Use of electron-beam sterilized hemodialysis membranes and risk of thrombocytopenia.

Kiaii M, Djurdjev O, Farah M, Levin A, Jung B, MacRae J.

JAMA. 2011 Oct 19;306(15):1679-87. doi: 10.1001/jama.2011.1499.

PMID:
22009100
3.

Hemodialysis-associated platelet loss: study of the relative contribution of dialyzer membrane composition and geometry.

Docci D, Turci F, Del Vecchio C, Bilancioni R, Cenciotti L, Pretolani E.

Int J Artif Organs. 1984 Nov;7(6):337-40.

PMID:
6526528
4.

Hemodialysis-associated platelet activation and thrombocytopenia.

Hakim RM, Schafer AI.

Am J Med. 1985 Apr;78(4):575-80.

PMID:
3885730
5.

Hemodialysis effect on platelet count and function and hemodialysis-associated thrombocytopenia.

Daugirdas JT, Bernardo AA.

Kidney Int. 2012 Jul;82(2):147-57. doi: 10.1038/ki.2012.130. Epub 2012 May 16. Review.

6.

Thrombocytopenia associated with use of a biocompatible hemodialysis membrane: a case report.

Post JB.

Am J Kidney Dis. 2010 Jun;55(6):e25-8. doi: 10.1053/j.ajkd.2009.10.059. Epub 2010 Jan 29.

PMID:
20110145
7.

Use of electron-beam sterilized hemodialysis membranes is not associated with significant 
and persistent thrombocytopenia.

Filiopoulos V, Manolios N, Vlassopoulos D.

Int J Artif Organs. 2013 Mar;36(3):217-9. doi: 10.5301/IJAO.5000186. Epub 2013 Feb 14.

PMID:
23408093
8.

Massive hemorrhage due to hemodialysis-associated thrombocytopenia.

Vicks SL, Gross ML, Schmitt GW.

Am J Nephrol. 1983 Jan-Feb;3(1):30-3.

PMID:
6601462
9.

Prevalence of heparin-induced antibody in African-American hemodialysis patients--comparison to non-dialysis patients.

Benjamin J, Moldavsky S, Lee J, Rubin R.

Clin Nephrol. 2009 Mar;71(3):263-6.

PMID:
19281736
10.

Fondaparinux therapy in a hemodialysis patient with heparin-induced thrombocytopenia type II.

Wellborn-Kim JJ, Mitchell GA, Terneus WF Jr, Stowe CL, Malias MA, Sparkman GM, Hanson GW.

Am J Health Syst Pharm. 2010 Jul 1;67(13):1075-9. doi: 10.2146/ajhp090394.

PMID:
20554593
11.

Evaluation of platelets and hemostasis during hemodialysis with six different membranes.

Verbeelen D, Jochmans K, Herman AG, Van der Niepen P, Sennesael J, De Waele M.

Nephron. 1991;59(4):567-72.

PMID:
1766495
12.

Acute profound thrombocytopenia associated with readministration of eptifibatide: case report and review of the literature.

Russell KN, Schnabel JG, Rochetto RP, Tanner MC.

Pharmacotherapy. 2009 Jul;29(7):867-74. doi: 10.1592/phco.29.7.867.

PMID:
19558261
13.

Severe thrombocytopenia possibly associated with TMP/SMX therapy.

Yamreudeewong W, Fosnocht BJ, Weixelman JM.

Ann Pharmacother. 2002 Jan;36(1):78-82.

PMID:
11816265
15.

Severe hypersensitivity reaction during hemodialysis.

Kraske GK, Shinaberger JH, Klaustermeyer WB.

Ann Allergy Asthma Immunol. 1997 Feb;78(2):217-20.

PMID:
9048531
16.

Heparin-induced antibodies and cardiovascular risk in patients on dialysis.

Asmis LM, Segal JB, Plantinga LC, Fink NE, Kerman JS, Kickler TS, Coresh J, Gardner LB.

Thromb Haemost. 2008 Sep;100(3):498-504.

PMID:
18766268
17.

The influence of dialyzer geometry on blood coagulation and biocompatibility.

Lins LE, Boberg U, Jacobson SH, Kjellstrand C, Ljungberg B, Skröder R.

Clin Nephrol. 1993 Nov;40(5):281-5.

PMID:
8281717
18.

[Clinical analysis of thrombocytopenia in chronic dialysis patients].

Iwamoto Y, Ando M, Tsuchiya K, Nihei H.

Nihon Jinzo Gakkai Shi. 1999 Oct;41(7):712-8. Japanese.

PMID:
10572397
19.

Heparin-induced thrombocytopenia associated with interleukin-8-dependent platelet activation in a patient with antiphospholipid syndrome.

Bounameaux C, Boehlen F, Membré A, Genné D, Pouplard C, Regnault V, de Moerloose P.

Eur J Haematol. 2007 Dec;79(6):550-3. Epub 2007 Oct 23.

PMID:
17961179
20.

Heparin-induced thrombocytopenia type II: a serious hazard in preemptive renal transplantation: a case report.

Dracopoulos S, Vougas V, Kassimatis TI, Theodoridis T, Ali ME, Apostolou T.

Transplant Proc. 2007 Dec;39(10):3481-4.

PMID:
18089414
Items per page

Supplemental Content

Write to the Help Desk